Milestones

2010

  • BIOTRONIK and Endosense sign international exclusive distribution partnership for Endosense’s force-sensing ablation catheter, the TactiCath® (available outside the U.S. only)
  • BIOTRONIK and Heartbeat International Foundation (HBI) join forces in order to save over 1000 lives in the poorest corners of the world
  • New complete portfolio of external devices for CRM is launched within only a few months
  • The Evia premium pacemaker series - one of the world's smallest - is launched globally
  • BIOTRONIK ProMRI®, a technology which allows patients to undergo MRI scans, is launched in the bradycardia and leads portfolio (available outside the U.S. only)
  • Lumax 540 VR-T DX is launched, the world's first and only single-chamber ICD system with full atrial diagnostics (available outside the U.S. only)
  • BIOTRONIK Home Monitoring® celebrates a decade of providing early detection and enhancing patient quality of care
  • BIOTRONIK Home Monitoring voted top innovation by Cardiostim delegates
  • BIOTRONIK Home Monitoring recieves the Frost & Sullivan Customer Service Leadership Award
  • Evia - the new technologically advanced pacemaker series from BIOTRONIK - receives U.S. FDA approval

2009

  • Evia - the new technologically advanced pacemaker series from BIOTRONIK - receives European CE approval
  • BIOTRONIK Home Monitoring receives FDA approval for labeling as providing early detection of arrhythmias, which allows for earlier intervention than conventional in-office follow-ups
  • Nominated for the German Federal President’s “Deutscher Zukunftspreis” (German Future Award): BIOTRONIK Home Monitoring for Online Monitoring of Heart Patients (available outside the U.S. only)
  • Company Announces FDA-Approved, Clinically-Supported Labeling Instructions. TRUST Study Affirms: BIOTRONIK Home Monitoring® Leads to Earlier Intervention
  • Global Launch of the new BIOTRONIK Home Monitoring, industry’s first and most advanced wireless remote monitoring system for patients with implantable cardiac devices now with an intelligent traffic light system

2008

  • BIOTRONIK receives approval for the new BIOTRONIK Home Monitoring industry’s first wireless remote monitoring technology with an intelligent traffic light system
  • TRUST Trial demonstrates BIOTRONIK Home Monitoring ensures patient safety and  provides earlier detection of arrhythmic events with fewer in-office visits
  • BIOTRONIK launches new state-of-the art ICD - Lumax 540 Series- the only cardiac devices with long-lasting therapies and Home Monitoring technology for improved patient care.
  • BIOTRONIK launches next generation pacemaker - Cylos 990 – offering advanced therapy for optimizing hemodynamics while streamlining patient follow-up (available outside the U.S. only)
  • BIOTRONIK announces start of patient enrolment into CASTLE-AF Study - world's largest randomized clinical study in patients suffering from heart failure and atrial fibrillation that will investigate superiority of catheter ablation vs. conventional treatment (available outside the U.S. only)
  • Next generation PRO-Kinetic Energy cobalt chromium coronary stent system receives European approval (available outside the U.S. only)
  • BIOTRONIK announce market introduction of the much anticipated Pantera balloon (available outside the U.S. only)
  • Excellent angiographic results at 6 months for the MultiBENE study using the PRO-Kinetic Stent System with its unique PROBIO silicon carbide coating (available outside the U.S. only)
  • BIOTRONIK launches new endovascular portfolio for BTK treatment including Astron Pulsar self-expanding stent compatible with 4 F sheath and 0.018" guidewire (available outside the U.S. only)
  • Specific PTA range of products for endovascular treatment of the inflow and outflow vessels has been completed with new over-the-wire catheters with small balloon diameters and long lengths, Passeo-18 and Passeo-35

2007

  • BIOTRONIK announces market introduction and first implantation of an innovative cardiac therapy system - Lumax XL - an ICD with extended longevity (available outside the U.S. only)
  • BIOTRONIK announces start of the REPLACE Trial in the USA
  • BIOTRONIK receives the EuroPCR 2007 Novelty Award for its innovative Absorbable Metal Stent (AMS) program (available outside the U.S. only)
  • PRO-Kinetic Stent System reported to show excellent safety and efficacy results in complex real-world patients (available outside the U.S. only)

2006

  • First implantation of Lumax HF T: This implant is the first therapy system for heart failure that permits fully automatic patient monitoring through telecardiology
  • Talos: the BIOTRONIK pacemaker in combination with Setrox S lead offers longevity greater than 11 years
  • Absorbable Metal Stent (AMS) results at 24 months continue to confirm the safety and efficacy of the technology (available outside the U.S. only)
  • BIOTRONIK concludes the European registry for the PRO-Kinetic cobalt chromium coronary stent (available outside the U.S. only)

2005

  • First implantation of a Cylos pacemaker with BIOTRONIK Home Monitoring and Closed Loop Stimulation, a world-wide unique physiologic rate-adaptive technology
  • Lumos: the first ICD worldwide that automatically transmits IEGMs (intracardiac ECGs) via the cell phone network. BIOTRONIK Home Monitoring of the third generation

2004

  • First human implantation of an absorbable metal scaffold (AMS) (available outside the U.S. only)
  • First implantation of a Kronos® LV-T device for cardiac resynchronization with defibrillation and Home Monitoring technology

2003

  • The Protos® VR and Protos DR pacemakers with BIOTRONIK's Closed Loop Stimulation (CLS) received FDA approval
  • With its golden tip electrode, the AlCath® Gold catheter for HF ablation creates lesions deeper by 30 % compared to common electrodes (available outside the U.S. only)
  • First over-the-wire lead implanted by BIOTRONIK
  • Pre-market study of the Philos® II with Active Capture Control.

2002

  • CE approval and first implantation of Philos® DR-T, a second-generation Home Monitoring pacemaker
  • CE approval of the Lekton® coronary stent for direct stenting (available outside the U.S. only)
  • U.S. approval of the Belos VR-T/DR-T, a dual-chamber ICD with Home Monitoring technology
  • New ViaCath catheter for intracardiac electrophysiological diagnostics (available outside the U.S. only)

2001

  • First implantation of the ICD Belos® VR-T with Home Monitoring technology
  • FDA approval of the first pacemaker with Home Monitoring technology

2000

  • Philos®, a complete series of pacemakers with telematics
  • SMART II, an algorithm for active discrimination of supraventricular arrhythmia
  • Home Monitoring and data management for pacemakers and ICDs
  • Triple-chamber stimulation for pacemakers (Triplos LV) and ICDs (Tupos LA and Tupos LV)
  • CE approval and first implantation of a pacemaker with Home Monitoring technology

1999

  • Tenax and Tenax XR coronary stents with radiopaque end segments (available outside the U.S. only)
  • Biventricular pacing

1998

  • Inos2+ CLS, Closed Loop Stimulation with automatic initialization
  • Multi-chamber (bi-atrial) stimulation devices
  • FAST, first automatic follow-up system for intuitive ICD programming
  • EPControl®, a computer-aided electrophysiological measurement system

1997

  • Phylax XM, the ICD with the largest diagnostic memory
  • MycroPhylax, the miniaturized ICD with the largest diagnostic memory and a dual-batter
  • Actros®, the pacemaker series that comes in a 6-mm wide casing
  • Tenax®, the coronary stent with optimized expansion characteristics

1996

  • Phylax AV, the dual-chamber ICD with the SMART discrimination algorithm
  • TMS 1000, the integrated programming and implantation test device

1995

  • Inos®, a rate-adaptive Closed Loop pacemaker
  • Phylax 06, the world's smallest ICD
  • Tensum®, the hypo-thrombogenic coronary stent
  • OLBI®, the overlapping biphasic impulse concept for single-lead dual-chamber pacemakers

1994

  • Physios® CTM 01, a pacemaker for transplant monitoring using the monophasic action potential (MAP) and the ventricular evoked response (VER) technologies
  • Single-lead VDD for pacing

1993

  • Phylax® 03, an implantable cardioverter-defibrillator (ICD) with fractal coated lead
  • Pacemakers used to monitor patients after a heart transplant

1991

  • Implantable fractal-coated leads

1990

  • NEOS-PEP, a rate-adaptive pacemaker with a pre-ejection phase measurement sensor

1988

  • Ergos® 01, an activity controlled rate-adaptive pacemaker

1986

  • Thermos 01, a rate-adaptive pacemaker with a central venous temperature measurement sensor

1983

  • Neos, the world's smallest single-chamber pacemaker with bi-directional telemetry

1981

  • Diplos® 03, a multi-programmable DDD pacemaker with bi-directional telemetry

1979

  • Nomos® 01, a multi-programmable VVI pacemaker

1976

  • The first BIOTRONIK pacemaker with a lithium battery, a hybrid circuit, and an hermetic MP35N housing (Protasul) 
  • Implantable DDD pacemaker
  • Single-channel monitoring via telephone

1975

  • Implantable low-polarization lead

1974

  • BIOTRONIK provides 3-year guarantee for pacemakers
  • Neurostimulator for the hypertension treatment using the baroreceptor concept

1972

  • Radionuclide-operated pacemaker (promethium battery)
  • Telephonic pacemaker monitoring

1970

  • Intra-aortic balloon pump to support the left ventricle for heart failure following myocardial infarction
  • BIOTRONIK provides 2-year guarantee for pacemakers

1968

  • First atrial lead with active fixation in the world
  • Semi-conductor lead for continuous measurement of pO2 and pH

1967

  • Atrial-controlled dual-chamber pacemaker (VAT) with a free-floating endocardial atrial lead

1966

  • Antitachycardia pacing
  • Stainless steel pacemaker housing

1965

  • BIO-Lock rapid connector port
  • First BIOTRONIK endocardial lead

1963

  • First BIOTRONIK pacemaker

 

 

PrintPrint Page MailE-Mail Page Text Size